New findings regarding the risks of over-the-counter probiotics in critically ill patients underscore the need for microbiota-targeted therapies that are based on efficacy in a disease- and host-specific context.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Suez, J., Zmora, N., Segal, E. & Elinav, E. Nat. Med. 25, 716–729 (2019).
Dermyshi, E. et al. Neonatology 112, 9–23 (2017).
Panigrahi, P. et al. Nature 548, 407–412 (2017).
Manzanares, W., Lemieux, M., Langlois, P. L. & Wischmeyer, P. E. Crit. Care 20, 262 (2016).
Varankovich, N. V., Nickerson, M. T. & Korber, D. R. Front. Microbiol. 6, 685 (2015).
Didari, T., Solki, S., Mozaffari, S., Nikfar, S. & Abdollahi, M. Expert Opin. Drug Saf. 13, 227–239 (2014).
Yelin, I. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0626-9 (2019).
Singer, J. R. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0640-y (2019).
Salminen, M. K. et al. Clin. Infect. Dis. 38, 62–69 (2004).
Kim, S. et al. Nature 572, 665–669 (2019).
Buffie, C. et al. Nature 517, 205–208 (2015).
Depommier, C. et al. Nat. Med. 25, 1096–1103 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Haak, B.W., Wiersinga, W.J. The differing roles of lactobacilli in critical illness. Nat Med 25, 1651–1653 (2019). https://doi.org/10.1038/s41591-019-0623-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41591-019-0623-z
